Orchestra BioMed Holdings reported earnings of -$ 0.30 per OBIO share on Nov 10, 2026, falling short of analysts' expectations by
| Report Date | Nov 10, 2026 |
|---|---|
| Forecasted EPS | -$ 0.40 |
| Earnings Per Share (Surprise) | -$ 0.30 (+$ 0.1007) |
| Last Year's EPS | -$ 0.30 |
| EPS YoY Change |
Out of the last 25 earnings reporting periods, Orchestra BioMed Holdings beat analysts’ expectations 12 times and fell short of expectations 4 time(s). Orchestra BioMed Holdings reported earnings per share of -$ 0.30 in the last report surpassing an estimated EPS of -$ 0.40 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 10, 2026 | -$ 0.40 | -$ 0.30 | -$ 0.40 | |
| Aug 10, 2026 | -$ 0.39 | -$ 0.38 | -$ 0.50 | |
| May 12, 2026 | -$ 0.40 | -$ 0.33 | -$ 0.43 | |
| Mar 12, 2026 | -$ 0.38 | $ 0.12 | -$ 0.37 | |
| Nov 10, 2025 | -$ 0.38 | -$ 0.40 | -$ 0.41 | |
| Aug 12, 2025 | -$ 0.51 | -$ 0.50 | -$ 0.45 | |
| Apr 2, 2025 | -$ 0.43 | -$ 0.43 | -$ 0.38 | |
| Mar 26, 2025 | -$ 0.43 | -$ 0.37 | -$ 0.37 | |
| Nov 12, 2024 | -$ 0.44 | -$ 0.41 | -$ 0.38 | |
| Aug 12, 2024 | -$ 0.41 | -$ 0.45 | -$ 0.35 | |
| May 13, 2024 | -$ 0.40 | -$ 0.38 | -$ 0.40 | |
| Mar 27, 2024 | -$ 0.38 | -$ 0.37 | -$ 2.08 | |
| Nov 13, 2023 | -$ 0.39 | -$ 0.38 | -$ 0.05 | |
| Aug 10, 2023 | -$ 0.42 | -$ 0.35 | -$ 3.71 | |
| May 12, 2023 | -$ 0.28 | -$ 0.40 | -$ 0.25 | |
| Jan 25, 2023 | -$ 3.14 | -$ 2.08 | -$ 0.25 | |
| Dec 16, 2022 | - | -$ 0.05 | -$ 0.18 | |
| Nov 14, 2022 | -$ 3.14 | -$ 3.71 | $ 0.00 | |
| Aug 15, 2022 | - | -$ 0.25 | $ 0.00 | |
| Jun 30, 2022 | - | -$ 0.25 | $ 0.00 |
Orchestra BioMed Holdings’s stock was trading at $ 5.70 on Nov 9, 2026 a day before the last earnings report was released.Following the release of the earnings report, OBIO’s price increased to $ 6.01 on Nov 11, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 10, 2026 | -$ 0.30 | $ 5.70 | $ 6.01 | |
| Aug 10, 2026 | -$ 0.38 | $ 4.24 | $ 4.40 | |
| May 12, 2026 | -$ 0.33 | $ 3.91 | $ 4.06 | |
| Mar 12, 2026 | $ 0.12 | $ 4.60 | $ 4.20 | |
| Nov 10, 2025 | -$ 0.40 | $ 3.81 | $ 4.10 | |
| Aug 12, 2025 | -$ 0.50 | $ 2.52 | $ 2.66 | |
| Apr 2, 2025 | -$ 0.43 | $ 3.24 | $ 3.11 | |
| Mar 26, 2025 | -$ 0.37 | $ 4.44 | $ 4.60 | |
| Nov 12, 2024 | -$ 0.41 | $ 6.13 | $ 6.07 | |
| Aug 12, 2024 | -$ 0.45 | $ 6.19 | $ 5.96 | |
| May 13, 2024 | -$ 0.38 | $ 4.71 | $ 5.20 | |
| Mar 27, 2024 | -$ 0.37 | $ 5.26 | $ 5.27 | |
| Nov 13, 2023 | -$ 0.38 | $ 5.27 | $ 6.83 | |
| Aug 10, 2023 | -$ 0.35 | $ 5.67 | $ 5.97 | |
| May 12, 2023 | -$ 0.40 | $ 17.00 | $ 17.43 | |
| Jan 25, 2023 | -$ 2.08 | $ 10.20 | $ 13.31 | |
| Dec 16, 2022 | -$ 0.05 | $ 9.96 | $ 9.97 | |
| Nov 14, 2022 | -$ 3.71 | $ 9.95 | $ 9.98 | |
| Aug 15, 2022 | -$ 0.25 | $ 9.86 | $ 9.86 | |
| Jun 30, 2022 | -$ 0.25 | $ 9.96 | $ 9.98 |
Orchestra BioMed Holdings released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Orchestra BioMed Holdings beat analysts’ expectations during the last earnings period by
